The estimated Net Worth of Partners Llcbalk Matthew Pe... is at least $6.47 million dollars as of 30 June 2017. Partners Pe owns over 160,000 units of AzurRx BioPharma Inc stock worth over $5,960,896 and over the last 8 years Partners sold AZRX stock worth over $510,400.
Sign up
Partners Pe AZRX stock SEC Form 4 insiders trading
Partners has made over 1 trades of the AzurRx BioPharma Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Partners sold 160,000 units of AZRX stock worth $510,400 on 30 June 2017.
The largest trade Partners's ever made was selling 160,000 units of AzurRx BioPharma Inc stock on 30 June 2017 worth over $510,400. On average, Partners trades about 80,000 units every 0 days since 2016. As of 30 June 2017 Partners still owns at least 1,727,796 units of AzurRx BioPharma Inc stock.
You can see the complete history of Partners Pe stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Partners Pe's mailing address?
Partners's mailing address filed with the SEC is PO BOX 2422PO BOX 2422, , WESTPORTWESTPORT, CTCT, 0688006880.
Insiders trading at AzurRx BioPharma Inc
Over the last 8 years, insiders at AzurRx BioPharma Inc have traded over $510,400 worth of AzurRx BioPharma Inc stock and bought 335,700 units worth $727,436 . The most active insiders traders include Charles J Casamento, Edmund Burke Jr. Ross et Partners Llcbalk Matthew Pe.... On average, AzurRx BioPharma Inc executives and independent directors trade stock every 82 days with the average trade being worth of $262,052. The most recent stock trade was executed by Johan M. Spoor on 28 December 2018, trading 38,583 units of AZRX stock currently worth $50,158.
What does AzurRx BioPharma Inc's logo look like?
Complete history of Partners Pe stock trades at AzurRx BioPharma Inc
AzurRx BioPharma Inc executives and stock owners
AzurRx BioPharma Inc executives and other stock owners filed with the SEC include:
-
James R. Sapirstein R.Ph., M.B.A.,
CEO, Pres & Non-Independent Director -
James Pennington,
Chief Medical Officer -
James Sapirstein,
President, Chief Executive Officer, Director -
Alastair Riddell,
Independent Director -
Edward Borkowski,
Independent Chairman of the Board -
Vern Schramm,
Independent Director -
Charles Casamento,
Independent Director -
Gregory Oakes,
Independent Director -
Daniel Schneiderman,
Chief Financial Officer -
Martin Krusin M.B.A.,
Sr. VP of Corp. Devel. -
Johan M. Spoor,
-
Partners Llcbalk Matthew Pe...,
-
Edmund Burke Jr. Ross,
-
Maged Shenouda,
CHIEF FINANCIAL OFFICER -
Daniel Dupret,
CHIEF SCIENTIFIC OFFICER -
Mary Theresa Coelho,